Mindfulness-Based Group Medical Visits: Strategies to Improve Equitable Access and Inclusion for Diverse Patients in Cancer Treatment.
Kavita K Mishra, Ivan C Leung, Maria T Chao, Ariana Thompson-Lastad, Christine Pollak, Anand Dhruva, Wendy Hartogensis, Michael Lister, Stephanie W Cheng, Chloe E Atreya
Global advances in integrative medicine and health 2024 DOI: 10.1177/27536130241263486 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Quality improvement project Qualitative Peer reviewed |
|---|---|
| Sample size | 78 |
| Population | Racially and ethnically diverse patients undergoing cancer treatment |
| Intervention | Mindfulness-based group medical visits (MB-GMVs) |
| Duration | Four weekly 2-hour visits |
| Topics | Meditation |
| Keywords | Group medical visits Health equity Integrative oncology Mind-body practices Mindfulness-based interventions |
| Citations | 5 |
| Key points | Telehealth mindfulness-based group medical visits are feasible, acceptable, and financially sustainable for increasing access to mindfulness-based interventions among diverse cancer patients in active treatment. |
Abstract
Mindfulness-based interventions (MBIs) are supported by clinical practice guidelines as effective non-pharmacologic interventions for common symptoms experienced by cancer patients, including anxiety, depression, and fatigue. However, the evidence predominately derives from White breast cancer survivors. Racial and ethnic minority patients have less access to integrative oncology care and worse cancer outcomes. To address these gaps, we designed and piloted a series of mindfulness-based group medical visits (MB-GMVs), embedded into comprehensive cancer care, for racially and ethnically diverse patients in cancer treatment. As a quality improvement project, we launched a telehealth MB-GMV series for patients undergoing cancer treatment, delivered as four weekly 2-hour visits billable to insurance. Content was concordant with evidence-based guidelines and established MBIs and adapted to improve cultural relevance and fit (eg, access-centered, trauma-informed, with inclusive communication practices). Program structure was adapted to address barriers to participation, with ≥50% slots per series reserved for racial and ethnic minority patients. Intake surveys incorporated a demographic questionnaire and symptom assessments. Evaluations were sent following the visits. In our first ten cohorts (n = 78), 80% of referred patients enrolled. Participants were: 22% Asian, 14% Black, 17% Latino, 45% non-Latino White; 65% female; with a median age of 54 years (range 27-79); and 80% had metastatic cancer. Common baseline symptoms included lack of energy, difficulty sleeping, and worrying. Most patients (90%) attended ≥3 visits. On final evaluations, 87% patients rated the series as "excellent"; 81% "strongly agreed" that they liked the GMV format; and 92% would "definitely" recommend the series to others. Qualitative themes included empowerment and connectedness. Telehealth GMVs are a feasible, acceptable, and financially sustainable model for increasing access to MBIs. Diverse patients in active cancer treatment were able to participate and reported high levels of satisfaction with this series that was tailored to center health equity and inclusion.